4-((2H-1,2,3-triazol-2-yl)methyl)piperidine hydrochloride, 95.0%, 500mg

Methyl 4-Hydroxybenzoate>99.0%(HPLC)(T)500g

cyclopropyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone, 97.0%, 1g

3-(Aminomethyl)oxetan-3-ol, 95.0%, 10g

(2E)-3-(4-bromophenyl)-1-(2,5-dichlorophenyl)prop-2-en-1-one, 95.0%, 2g

4-NITRONAPHTHALEN-2-OL, 95%, 100mg

3-CHLORO-6-NITRO-1H-INDAZOLE, 97%, 1g

2-Chloro-1-(1-methyl-1h-pyrazol-4-yl)ethan-1-one, 95%, 5g

4-Benzenesulfonyl-butyric acid, 1g

2-(1-(4-Chlorophenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

1-Bromo-3,4-difluoro-2-methoxybenzene, 95.0%, 10g

Lithium sulphate, min. 99%, anhydrous, 100 g, plastic packaging.

Substance P, 95.0%, 10mg